Morgan Stanley’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $429K | Sell |
92,788
-76,324
| -45% | -$289K | ﹤0.01% | 5619 |
|
|
2026
Q1 | $489K | Buy |
169,112
+8,096
| +5% | +$17.3K | ﹤0.01% | 5495 |
|
|
2025
Q4 | $259K | Sell |
161,016
-828,217
| -84% | -$1.3M | ﹤0.01% | 5819 |
|
|
2025
Q3 | $1.66M | Buy |
989,233
+543,011
| +122% | +$879K | ﹤0.01% | 4895 |
|
|
2025
Q2 | $540K | Buy |
446,222
+104,737
| +31% | +$152K | ﹤0.01% | 5431 |
|
|
2025
Q1 | $434K | Sell |
341,485
-762,941
| -69% | -$1.99M | ﹤0.01% | 5395 |
|
|
2024
Q4 | $3.59M | Buy |
1,104,426
+784,557
| +245% | +$2.83M | ﹤0.01% | 4276 |
|
|
2024
Q3 | $1.05M | Sell |
319,869
-152,368
| -32% | -$594K | ﹤0.01% | 5017 |
|
|
2024
Q2 | $2.01M | Buy |
472,237
+260,289
| +123% | +$2.53M | ﹤0.01% | 4564 |
|
|
2024
Q1 | $3.12M | Sell |
211,948
-139,227
| -40% | -$2.1M | ﹤0.01% | 4290 |
|
|
2023
Q4 | $3.38M | Sell |
351,175
-2,102
| -0.6% | -$14.5K | ﹤0.01% | 4190 |
|
|
2023
Q3 | $1.65M | Sell |
353,277
-90,478
| -20% | -$450K | ﹤0.01% | 4509 |
|
|
2023
Q2 | $2.37M | Sell |
443,755
-199,699
| -31% | -$1.23M | ﹤0.01% | 4310 |
|
|
2023
Q1 | $4.61M | Sell |
643,454
-3,768
| -0.6% | -$22.7K | ﹤0.01% | 3846 |
|
|
2022
Q4 | $4.34M | Sell |
647,222
-132,126
| -17% | -$725K | ﹤0.01% | 3877 |
|
|
2022
Q3 | $2.7M | Buy |
779,348
+101,899
| +15% | +$390K | ﹤0.01% | 4223 |
|
|
2022
Q2 | $2M | Buy |
677,449
+64,335
| +10% | +$338K | ﹤0.01% | 4542 |
|
|
2022
Q1 | $5.4M | Buy |
613,114
+367,149
| +149% | +$4.05M | ﹤0.01% | 3611 |
|
|
2021
Q4 | $3.95M | Buy |
245,965
+210,621
| +596% | +$3.96M | ﹤0.01% | 3964 |
|
|
2021
Q3 | $740K | Sell |
35,344
-171,738
| -83% | -$4.14M | ﹤0.01% | 5256 |
|
|
2021
Q2 | $5.56M | Buy |
207,082
+186,543
| +908% | +$5.46M | ﹤0.01% | 3667 |
|
|
2021
Q1 | $654K | Sell |
20,539
-35,761
| -64% | -$868K | ﹤0.01% | 4999 |
|
|
2020
Q4 | $1.29M | Buy |
56,300
+19,211
| +52% | +$442K | ﹤0.01% | 4506 |
|
|
2020
Q3 | $934K | Buy |
37,089
+2,077
| +6% | +$56.7K | ﹤0.01% | 4254 |
|
|
2020
Q2 | $978K | Buy |
35,012
+8,849
| +34% | +$154K | ﹤0.01% | 4190 |
|
|
2020
Q1 | $153K | Sell |
26,163
-59,079
| -69% | -$536K | ﹤0.01% | 4989 |
|
|
2019
Q4 | $928K | Buy |
85,242
+29,537
| +53% | +$292K | ﹤0.01% | 4587 |
|
|
2019
Q3 | $711K | Buy |
55,705
+5,103
| +10% | +$73.5K | ﹤0.01% | 4489 |
|
|
2019
Q2 | $859K | Buy |
50,602
+3,358
| +7% | +$57.7K | ﹤0.01% | 4306 |
|
|
2019
Q1 | $849K | Sell |
47,244
-19,749
| -29% | -$341K | ﹤0.01% | 4228 |
|
|
2018
Q4 | $851K | Sell |
66,993
-47,933
| -42% | -$804K | ﹤0.01% | 4397 |
|
|
2018
Q3 | $2.46M | Buy |
114,926
+6,842
| +6% | +$146K | ﹤0.01% | 3839 |
|
|
2018
Q2 | $2.23M | Sell |
108,084
-66,339
| -38% | -$1.49M | ﹤0.01% | 3971 |
|
|
2018
Q1 | $4.39M | Buy |
174,423
+99,836
| +134% | +$2.42M | ﹤0.01% | 3160 |
|
|
2017
Q4 | $1.42M | Buy |
74,587
+398
| +0.5% | +$7.43K | ﹤0.01% | 4314 |
|
|
2017
Q3 | $1.37M | Buy |
74,189
+11,822
| +19% | +$205K | ﹤0.01% | 4208 |
|
|
2017
Q2 | $1.09M | Buy |
62,367
+5,144
| +9% | +$98.1K | ﹤0.01% | 4309 |
|
|
2017
Q1 | $1.06M | Sell |
57,223
-37,474
| -40% | -$723K | ﹤0.01% | 4340 |
|
|
2016
Q4 | $1.94M | Buy |
94,697
+81,883
| +639% | +$2.06M | ﹤0.01% | 3957 |
|
|
2016
Q3 | $384K | Buy |
12,814
+3,328
| +35% | +$99K | ﹤0.01% | 4679 |
|
|
2016
Q2 | $256K | Sell |
9,486
-11,829
| -55% | -$267K | ﹤0.01% | 4811 |
|
|
2016
Q1 | $400K | Buy |
21,315
+19,738
| +1,252% | +$376K | ﹤0.01% | 4575 |
|
|
2015
Q4 | $49K | Buy |
1,577
+439
| +39% | +$13.3K | ﹤0.01% | 5723 |
|
|
2015
Q3 | $24K | Sell |
1,138
-6,561
| -85% | -$206K | ﹤0.01% | 5990 |
|
|
2015
Q2 | $292K | Buy |
7,699
+4,863
| +171% | +$160K | ﹤0.01% | 5048 |
|
|
2015
Q1 | $89K | Sell |
2,836
-113,689
| -98% | -$3.85M | ﹤0.01% | 5580 |
|
|
2014
Q4 | $4.09M | Buy |
116,525
+102,581
| +736% | +$2.56M | ﹤0.01% | 2916 |
|
|
2014
Q3 | $292K | Sell |
13,944
-9,949
| -42% | -$206K | ﹤0.01% | 4923 |
|
|
2014
Q2 | $519K | Buy |
23,893
+22,433
| +1,537% | +$472K | ﹤0.01% | 4544 |
|
|
2014
Q1 | $41K | Sell |
1,460
-63,474
| -98% | -$2.24M | ﹤0.01% | 5782 |
|
|
2013
Q4 | $1.78M | Buy |
+64,934
| New | +$1.7M | ﹤0.01% | 3469 |
|
Other funds holding MGNX
AC
WA
RCM
Morgan Stanley's MGNX Position: Q2 2026 in Review
Morgan Stanley reduced its MacroGenics (MGNX) stake by 45% in Q2 2026, selling an estimated $289K and leaving 92,788 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #5619.
Morgan Stanley first reported a position in MGNX in Q4 2013 and has held it in 51 quarters since. The position peaked at $5.56M in Q2 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.
- Morgan Stanley held 92,788 shares of MacroGenics worth $429K as of Q2 2026.
- Morgan Stanley sold 76,324 MacroGenics shares in Q2 2026, an estimated $289K.
- MacroGenics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5619 holding.
- Morgan Stanley first reported a position in MacroGenics in Q4 2013 and has held it in 51 quarters since.
- Morgan Stanley's MacroGenics position peaked at $5.56M in Q2 2021.
- 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.